The outer mitochondrial membrane translocator protein (TSPO) binds cholesterol with high affinity and is involved in mediating its delivery into mitochondria, the rate-limiting step in hormoneinduced steroidogenesis. Specific ligand binding to TSPO has been shown to initiate steroid formation. However, recent studies of the genetic deletion of Tspo have provided conflicting results. Here, we address and extend previous studies by examining the effects of Tspo-specific mutations on steroid formation in hormone-and cyclic adenosine monophosphate (cAMP)-responsive MA-10 cells, using the CRISPR/Cas9 system. Two mutant subcell lines, nG1 and G2G, each carrying a Tspo exon2-specific genome modification, and two control subcell lines, G1 and HH, each carrying a wildtype Tspo, were produced. In response to dibutyryl cAMP, the nG1 and G2G cells produced progesterone at levels significantly lower than those produced by the corresponding control cells G1 and HH. Neutral lipid homeostasis, which provides free cholesterol for steroid biosynthesis, was altered significantly in the Tspo mutant cells. Interestingly, the mitochondrial membrane potential (DC m ) of the Tspo mutant cells was significantly reduced compared with that of the control cells, likely because of TSPO interactions with the voltage-dependent anion channel and tubulin at the outer mitochondrial membrane. Steroidogenic acute regulatory protein (STAR) expression was induced in nG1 cells, suggesting that reduced TSPO affected STAR synthesis and/or processing. Taken together, these results provide further evidence for the critical role of TSPO in steroid biosynthesis and suggest that it may function at least in part via its regulation of DC m and effects on STAR. (Endocrinology 159: 1130(Endocrinology 159: -1146(Endocrinology 159: , 2018 S teroid hormone biosynthesis begins with the conversion of cholesterol to pregnenolone by the mitochondrial enzyme CYP11A1. This reaction is dependent in part upon delivery of cholesterol from intracellular stores into mitochondria, the latter constituting the rate-determining step in steroidogenesis. Transport of free cholesterol to mitochondria for steroid biosynthesis involves steroidogenic acute regulatory protein (STAR or STARD1), soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins, and interactions of lipid droplets (LDs) with mitochondria and of mitochondria with the endoplasmic reticulum (1-7). STAR and soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins were shown to function
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Translocator protein (TSPO; 18 kDa) is a wellconserved, ubiquitous, integral OMM protein that is abundant in steroid-synthesizing cells. With its high affinity for cholesterol, TSPO is able to segregate cholesterol and to participate in its targeting to CYP11A1 (10, 11) . Cholesterol binds at a specific binding site of TSPO, the latter termed the cholesterol recognition/interaction amino acid consensus motif (12) (13) (14) . TSPO-mediated cholesterol targeting to CYP11A1 is likely achieved through the formation of a multiprotein complex of OMM and IMM proteins, including TSPO, voltagedependent anion channel (VDAC), adenosine triphosphatase family AAA domain-containing protein 3, and CYP11A1 (11) . TSPO binds with high affinity to diverse compounds and endogenous ligands that can regulate its activity (5) . Biochemical and pharmacological studies using TSPO ligands strongly support the contention that TSPO plays an important role in cholesterol import into mitochondria and thus in steroidogenesis (5, 15, 16) . TSPO abundance in steroidogenic cells may be linked to the tissue/cell-specific need for the amounts of free cholesterol to be imported into mitochondria. The presence of TSPO and cholesterol in the OMM may affect mitochondrial membrane fluidity/permeability, fission/fusion processes, membrane protein/transporter function(s), and membrane potential (DC m ) (17) (18) (19) .
Recent studies of genetic deletion of Tspo in mice have provided conflicting data, including no effect on steroid synthesis, ablation of corticosteroid response to adrenocorticotropic hormone, and changes in lipid homeostasis in testicular Leydig cells (20) (21) (22) (23) . Conflicting data based on MA-10 mouse Leydig cells also have been published. Thus, knockdown of Tspo expression using antisense oligonucleotides was reported to reduce the ability of the cells to form steroids, but CRISPR/Cas9-guided Tspo deletion was reported to have no effect on steroid synthesis (24) (25) (26) .
The current studies were designed to reevaluate the effect of CRISPR/Cas9-guided Tspo deletion on the ability of MA-10 cells to form steroids and to further our understanding of how TSPO functions in this process. TSPO deficiency led to reduced dibutyrylcyclic adenosine monophosphate (dbcAMP)-stimulated steroid biosynthesis and increased esterified, cholesterolenriched neutral lipid accumulation, suggesting reduction in the import of the steroidogenic pool of cholesterol into mitochondria. Data suggest that this is most likely due to TSPO-mediated reduced mitochondrial DC m via regulation of VDAC1/tubulin interaction. In addition, we show that STAR levels were increased in TSPO-deficient cells, suggesting that increased STAR expression levels and/or altered STAR processing might compensate to some extent for reduced TSPO. These results support the contention that TSPO plays a major role in steroid biosynthesis and further suggest that TSPO may function at least in part via regulation of DC m and effects on STAR.
Materials and Methods

Cell culture
MA-10 cells were maintained in Dulbecco's modified Eagle medium/F-12 medium supplemented with 5% heat-inactivated fetal bovine serum and 2.5% horse serum (27) . The MA-10-derived wild-type (WT) subcell lines and the Tspo genomeedited subcell lines nG1 and G2G were grown in this medium supplemented with 400 mg/mL of G418 (Roche Diagnostics, Indianapolis, IN), 100 U/mL of penicillin, and 100 mg/mL of streptomycin in 5% CO 2 /air at 37°C, as described previously (28) . The cells used for confocal microscopy and microplate reader studies were cultured on single 35- CRISPR/Cas9-mediated genome editing of Tspo genes in MA-10 cell lines Two guide RNAs (gRNAs) specifically targeting Tspo exon2 were designed using the CRISPR gRNA Design Tool (https:// www.atum.bio). They were cloned into the GeneArt ® CRISPR Nuclease Vector with OFP Reporter (Thermo Fisher Scientific, Mississauga, ON, Canada) through annealing of the following two oligonucleotides: Tspo-gRNA#1 -gRNA1-Rn: 5 0 -GCC-TACTTTGTACGTGGCGAGTTTT-3 0 and gRNA1-Fn: 5 0 -TCGCCACGTACAAAGTAGGCCGGTG-3 0 ; Tspo-gRNA#2 -gRNA2-Rn: 5 0 -GCAAGCTAGCATACCACCGGGTTTT-3 0 and gRNA2-Fn: 5 0 -CCGGTGGTATGCTAGCTTGCCGGTG-3 0 . The orange fluorescent protein (OFP) reporter allows for the transient expression of the OFP needed for fluorescencebased tracking of transfection efficiency and fluorescenceactivated cell sorting (FACS)-based sorting/enrichment of Cas9-and CRISPR-expressing cells. All the plasmids that contained the gRNAs were confirmed by sequencing, using U6 forward sequencing primer 5 0 -GGACTATCATATGCTTACCG-3 0 . The verified plasmids were purified with a Qiagen Endofree MaxiPrep Kit (QIAGEN, Germantown, MD).
To monitor mitochondrial activity, we established a subcell line derived from MA-10 cells, designated Mito-H, in which a mitochondrial reduction-oxidation sensitive green fluorescent protein 1 (Mito-roGFP) was stably expressed (28) . The Mito-H cells expressed high levels of Mito-roGFP and formed progesterone in response to dbcAMP (28) . Mito-H cells were cultured overnight in six-well plates to 80% confluence and then transfected with the GeneArt CRISPR Nuclease Vector with OFP Reporter containing each Tspo-specific gRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. After 24-hour transfection, the cells were subjected to FACS using BD FACSAria Fusion (five lasers, 18 parameters; BD Biosciences, San Jose, CA), and the positive cells were sorted and expanded. Tspo deletion was confirmed by polymerase chain reaction of genomic DNA using the Tspo-specific primers Exon2-R, 5
0 -TCAGATCTTTCCA-GAACATCAGTTGC-3 0 and Exon2-F, 5 0 -TGGCACCTA-CAACTACCTACCCCATGG-3 0 and reverse transcription polymerase chain reaction using primers TSPO-R, 5
0 -GCG-AAGCTTCGATGCCTGAATCCTGGGTGCC-3 0 and TSPO-F, 5
0 -GCGGGATCCCTCACTCTGGGAGCCGGGAGCC-3 0 . Immunoblotting assay was performed using commercial anti-TSPO antibodies (Abs) ( Table 1) , and immunofluorescence was carried out using a laser-scanning confocal microscopy imaging system and epifluorescence microscopy.
Radioimmunoassay
Progesterone production was determined by radioimmunoassay using antiprogesterone antisera (MP Biomedicals, Santa Anna, CA) and [1, 2, 6, H] progesterone (specific activity 94.1 Ci/mmol; PerkinElmer), as we have done previously (28) . The interassay coefficient of variation for the progesterone assay was 7.5%. All measurements were further validated using the solid-phase enzyme immunoassay. All samples were assayed in triplicate. Mean values of progesterone in medium from four biological replicates ranged between 25.19 and 326.65 pg/mL, and the %B/B 0 values were from 44.6% to 78.5%, which are within the 20% to 80% B/B 0 range. Progesterone production was normalized to the amount of protein in each well and quantified using the Bio-Rad Protein Assay reagent (Bio-Rad Laboratories Ltd., Mississauga, ON, Canada). Radioimmunoassay data were analyzed using GraphPad Prism (version 5.02; GraphPad Software, La Jolla, CA).
Neutral lipid staining and measurement
Neutral lipid staining was performed using Nile red (also known as Nile blue oxazone; AAT Bioquest, Inc., San Francisco, CA). To this end, cells were incubated at 37°C for 10 minutes in a solution of Nile red in dimethyl sulfoxide (DMSO) diluted 1:200 in serum-free OPTI medium (Invitrogen). Cells were observed by confocal microscopy to monitor fluorescence change at excitation/ emission (Ex/Em) = 488/528 nm. The stained LDs were quantified using ImageJ software (https://imagej.nih.gov/ij/).
Mitochondrial staining and transmission electron microscopy imaging
To stain mitochondria, the cells were grown to 50% confluence, treated with 1 mM of dbcAMP for 2 hours, and then stained with MitoTracker Red CMXRos (Invitrogen) for 20 minutes at 37°C. Live cells were observed by Zeiss LSM780 inverted laser scanning confocal microscopy (Carl Zeiss Microscopy LLC, Thornwood, NY). Transmission electron microscopy (TEM) imaging was performed at the Facility for Electron Microscopy Research of McGill University (7). In brief, subcell lines were fixed in 2.5% glutaraldehyde in 0.1 M of sodium cacodylate buffer, postfixed in 1% OsO 4 , and examined by TEM (Tecnai  TM 12 ; FEI, Hillsboro, OR). Mitochondrial Dc m , redox measurement, and high-content imaging
To assay mitochondrial Dc m , MA-10 and MA-10-derived cells were washed with reduced-serum medium (Opti-MEM; Thermo Fisher Scientific), treated without or with 1 mM of dbcAMP for 2 hours, and then stained with JC-10 (1:600) for 30 minutes. The plates were read using the PerkinElmer EnSpire Multimode Plate Reader with Ex/Em = 485/534 nm or 540/570 nm. The same plates were imaged using the ImageXpress micro XLS wide-field high-content analysis system (Molecular Devices, Sunnyvale, CA) or an ultraconfocal high-content analysis system to validate the plate readings. For HH and G2G subcell lines with stable MitoroGFP expression, Dc m was measured using the TMREMitochondrial Membrane Potential Assay Kit (Abcam, Toronto, ON, Canada). Tetramethylrhodamine ethyl ester (TMRE) was used to treat the cells without or with carbonyl cyanide 4- For immunofluorescence staining, the cells were fixed in a 4% paraformaldehyde solution plus 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 5 minutes and washed in PBS for 5 minutes. After blocking with 1% bovine serum albumin in PBS plus 10% donkey normal serum for 30 minutes at 37°C, the cells were incubated with rabbit anti-TSPO mono- Detection of caspase-3/7 activity and cell proliferation and viability assay
To assess whether the reduced progesterone production in cells with TSPO deficiency was due to programmed cell death induced by the dbcAMP treatment, we treated the cells with dbcAMP for 2 hours, then added CellEvent TM caspase-3/7 green detection reagent (1:600; Thermo Fisher Scientific) for 30 minutes before imaging with the Olympus Fluoview TM FV1000 laser confocal microscope. Apoptotic cells (green) and nonapoptotic cells (counterstained blue) were counted using Image-Pro 6.3 (Media Cybernetics Inc., Silver Spring, MD). Cell proliferation assays were performed using the WST-1 colorimetric test, which measures mitochondrial dehydrogenase activity by the cleavage of the tetrazolium salt WST-1 to form a red formazan dye by viable cells (Cell Proliferation Reagent WST-1; Roche). Cells were seeded at the same density in serum-free media. Cell density per well before and after dbcAMP treatment was assessed by collecting OD450nm/620 nm values using the Victor TM X5 2030 Multilabel Reader (PerkinElmer, Waltham, MA).
Immunoblot analysis
Total protein extracts for immunoblot analysis were prepared from MA-10 cells and its derived cell lines using M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific). After centrifugation, protein concentration was quantified using the Bradford dye assay (Bio-Rad Laboratories Ltd.). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analysis were performed as previously described (29) . In brief, 20 mg of protein extract was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a 4% to 20% Tris-glycine gradient gel (Invitrogen) and electrotransferred to a polyvinylidene fluoride membrane. Membranes were blocked in 10% fat-free milk overnight and incubated with primary Abs specific for TSPO, glyceraldehyde-3-phosphate dehydrogenase, hypoxanthine-guanine phosphoribosyltransferase, STAR, CYP11A1, or COX IV, followed by anti-rabbit immunoglobulin-G horseradish peroxidase-conjugated secondary Ab (Cell Signaling Technology, Danvers, MA). Information about the Abs and dilutions used are provided in Table 1 . In the case of anti-STAR immunoblot, the membranes were stripped of the Ab using Restore™ Western Blot Stripping Buffer (Thermo Fisher Scientific) and were reprobed using anti-COX IV. Immunoreactive proteins were visualized using the Amersham ECL Western Blotting Detection Reagent (GE Healthcare Life Sciences, Mississauga, ON, Canada), and images were captured using a FUJI image reader LAS4000 (Fujifilm, Tokyo, Japan).
Molecular modeling
The predicted secondary structure of TSPO was produced using TMRPres2D (30) . The molecular surfaces of WT TSPO (PDB: 2MGY) were produced after removal of PK 11195 and with minimized energy in the Swiss-PdbViewer (V.4.1) (31, 32) .
Statistical analysis
Data were expressed as mean 6 standard error of the mean, and graphic presentation was performed using GraphPad Prism (version 5.02; GraphPad Software) for Windows. Statistical analyses of data were performed by the unpaired Student t test. Mean differences were considered statistically different when P , 0.05.
Results
CRISPR/Cas9-mediated Tspo deletion mutation in MA-10 cells
To generate Tspo mutant/deleted cell lines, we designed two gRNAs specifically targeting Tspo exon2. The two, gRNA1 (in red) and gRNA2 (in green), were cloned into the GeneArt ® CRISPR Nuclease Vector with OFP Reporter ( Fig. 1A and 1B) . After their transfection into cells of the MA-10 subline Mito-H, we performed FACS analysis that resulted in four major groups of cell populations [quarter (Q) 1, Q2, Q3, and Q4]: G1, cells expressing OFP without detectable gene deletion; nG1, cells expressing OFP with detectable Tspo-targeted gene deletion; G2G, cells expressing both Mito-roGFP and OFP with Tspotargeted gene deletion; and HH, cells expressing Mito-GFP without Tspo gene deletion (Fig. 1C and 1D) . The Tspospecific gene deletions were confirmed by locus-specific polymerase chain reaction and sequencing in comparison with the WT gene sequence (Supplemental Fig. 1A-1C) . The characteristics of each MA-10-derived subcell line are summarized in Table 2 . After expansion of the cell colonies, immunoblotting analyses were performed to validate the TSPO protein depletion or mutation. The results showed that no immunoreactive TSPO protein could be detected in G2G cells (Supplemental Fig. 1D ), a result supported by reverse transcription polymerase chain reaction analysis showing that the sizes of corresponding messenger RNA shifted, especially in the nG1 cells (Supplemental Fig. 1E ). In addition, immunoblotting analysis of the nG1 cells showed that the 18 kDa TSPO protein monomer disappeared, although a higher molecular weight immunoreactive TSPO polymer appeared (Supplemental Fig. 1F ). We also assessed whether the expression levels of CYP11A1, the mitochondrial enzyme that catalyzes conversion of cholesterol to pregnenolone, were affected by the genome editing system. The results show that the subcell line contained CYP11A1 at levels equal to those of WT cells (Supplemental Fig. 1G ). These data suggest that Tspo in both nG1 and G2G was successfully mutated using the CRISPR/Cas9 methodology, resulting in depletion of the 18 kDa TSPO or dramatic reduction of its expression.
Immunofluorescence analyses of WT and Tspo-deleted cell lines by confocal laser scanning microscopy and epifluorescence microscopy show that the WT TSPO was expressed on the OMM (Fig. 1E, 1G , 1I, and 1K; Supplemental Fig. 2A and 2C ). However, in the Tspo mutant cells, there were no or very few cells stained by the anti-TSPO Ab (Fig. 1F, 1H , 1J, and 1L; and Supplemental Fig. 2B and 2D ). These data suggest that TSPO was mutated and/or depleted in the MA-10 subcell lines nG1 and G2G, whereas the expression of TSPO in the corresponding original MA-10 subcell lines G1 and HH was not affected.
TSPO deficiency inhibited dbcAMP-stimulated progesterone production
The sequence alignment of the targeting regions from WT, nG1, and G2G cells indicated the deletion of four nucleotide acids, "GTGG," in G2G and 26 nucleotide acids, "TGTACGTGGCGAGGGCCTCCGGTGGT," in nG1 ( Fig. 2A) . The corresponding open reading frames were aligned to show that both Tspo mutant cells likely encode an N-terminal truncated protein, as shown in the amino acid sequence alignment (Fig. 2B ) and secondary structure of the WT TSPO (Supplemental Fig. 3A) . Nevertheless, the mutant TSPO from both cell lines, if any was expressed, may not have functioned the same as WT TSPO because its molecular surface would be changed from a positive potential to a neutral potential (Supplemental Fig. 3B) .
To examine the effect of mutant TSPO on Leydig cell steroid biosynthesis, we assessed progesterone production by nG1 and G2G cells under basal conditions and in response to dbcAMP treatment. There were no significant changes in basal progesterone production between TSPO mutant nG1 and G2G cells compared with their respective control G1 and HH cells (Fig. 2C and 2E) . However, progesterone production in response to dbcAMP treatment was abolished in nG1 cells compared with control G1 cells (Fig. 2D) and was significantly reduced, by 60% in G2G cells compared with their control HH cells (Fig. 2F) .
TSPO deficiency led to neutral lipid accumulation after dbcAMP stimulation
To interpret reduced progesterone biosynthesis by cells with TSPO deficiency, we speculated that the free cholesterol used for steroid biosynthesis would accumulate in the cytosol. In steroidogenic cells, free cholesterol can be stored in LDs containing a neutral lipid core surrounded by a phospholipid monolayer and associated proteins (33) . We used Nile red to stain the neutral lipids in LDs (Fig. 2G-2J) . In control G1 cells, dbcAMP stimulation resulted in significant reduction in LDs, suggesting that LDs were used to supply cholesterol for steroidogenesis. In contrast, there was a significant increase in LD numbers in dbcAMP-stimulated TSPOdeficient nG1 cells (Fig. 2K ). These data suggest that the free cholesterol used for steroid biosynthesis was compromised in the TSPO-deficient cells, leading to LD accumulation.
TSPO deficiency resulted in changes in mitochondrial morphology and in OMM and IMM contact sites and/or fusion MitoTracker probes are cell-permeable, mitochondriaselective dyes that passively diffuse across the plasma membrane and accumulate in active mitochondria. We used these probes to examine whether there are changes in mitochondrial morphology in cells depleted of TSPO. Untreated cells or cells treated with dbcAMP were stained with Mitotracker Red CMXRos (Invitrogen) ( Fig. 3;  Supplemental Fig. 4 ). Mitochondrial morphology in G1 (Fig. 3A-3C ) and nG1 ( Fig. 3D-3F ) cells in response to dbcAMP treatment differed with mitochondrial swelling seen in nG1 cells (compare Fig. 3C with Fig. 3F ).
We then examined subcellular features of the mitochondria by TEM. In the control G1 cells, the mitochondrial membranes were distinct and of high density. The membranes became more diffuse after the cells were treated with dbcAMP ( Fig. 3G and 3H ). These observations are consistent with those from MitoTracker staining (Fig. 3C) . In TSPO-depleted nG1 cells, the two mitochondrial membranes were separate but with a number of contact sites (Fig. 3I) . After dbcAMP treatment, the OMM and IMM of these cells were fused (Fig. 3J) . In contrast to analysis of nG1 cells, confocal and TEM analyses of TSPO-depleted G2G cells indicated that there were no remarkable changes in mitochondrial morphology from the control HH cells. However, staining with MitoTracker differed somewhat between G2G and HH cells, appearing more in the periphery rather than inside the mitochondria in G2G cells (Supplemental Fig. 4) .
The Mito-roGFP1 probe in Mito-H cells and its subcell lines is in dynamic equilibrium with the mitochondrial redox status and responds to membrane-permeable reductants and oxidants (35) . Thus, Mito-roGFP (in green), which was used to monitor the redox status, was counterstained with MitoTracker ( Supplemental Fig. 4B,  4D , 4G, and 4H). Although control HH cells treated with dbcAMP showed reduced roGFP staining at 480 nM, indicating changes in the mitochondrial redox conditions (Supplemental Fig. 4B and 4D) , there was no change in TSPO-depleted G2G cells (Supplemental Fig. 4F and 4H ). These observations are consistent with the direct measurement of redox status (400/488 ratio) between these two cell lines and indicate that the presence of TSPO is related to mitochondrial redox homeostasis (see later).
TSPO deficiency resulted in reduced mitochondrial Dc m
The cationic and lipophilic JC-10 dye, a derivative of JC-1 (5, 5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazoyl carbocyanine iodide), has been widely used to monitor mitochondrial health via its reversible changes from red fluorescence in normal cells to green fluorescence in apoptotic and necrotic cells as membrane potential decreases (36) (37) (38) . JC-10 staining was performed to assess changes in mitochondrial Dc m in the control and TSPO-mutant cells. Dc m was significantly reduced in the TSPO-deficient nG1 cells compared with the control G1 cells. Treatment with dbcAMP further reduced Dc m in nG1 cells (Fig. 4A) . Examination of the stained cells from high-content imaging similarly revealed mitochondrial color shift from red to green with TSPO depletion (compare Fig. 4B with Fig. 4C ) and after dbcAMP treatment (compare Fig. 4D with Fig.  4E ). In HH and G2G cells expressing Mito-roGFP, we used TRME staining, which emits red fluorescence, to assess changes in Dc m . The results showed that Dc m was significantly reduced in TSPO-deficient G2G compared with control HH cells (Fig. 4F) . However, the reduced Dc m was not as low as that seen using the mitochondrial oxidative phosphorylation uncoupler (FCCP) or as much as that seen in nG1 cells, where TSPO expression was absent (Fig. 4E  and 4A ). These results indicate that TSPO deficiency leads to mitochondrial depolarization.
Decreased Dc m and progesterone synthesis in Tspo mutant cells were TSPO specific Two TSPO-specific ligands, PK 11195 (100 nM; Sigma-Aldrich Canada Ltd.) and XBD173 (20 mM; Tractus Chemical), were used to treat cells. Both compounds (Fig. 5A and 5B). The cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) inhibitor H-89 (Sigma-Aldrich), used at 1 and 10 mM, increased the Dc m in all cells examined (Fig. 5C) , suggesting that the repressed Dc m in TSPO-deficient cells can be recovered. TSPO deficiency led to a significantly elevated mitochondrial oxidized condition, but no changes were seen after PK 11197 or XBD173 treatment ( Fig. 5D and 5E ). Treatment with dbcAMP decreased the Dc m in controls but not in TSPO-deficient cells (Fig. 5F ). Under the same conditions, control HH but not TSPO-deficient G2G cells responded to PK 11195 by producing increased levels of progesterone (Fig. 5G) . Moreover, although TSPO-deficient cells were characterized by low Dc m , they were resistant to apoptosis and had similar relative proliferation rates before and after dbcAMP treatment (Supplemental Fig. 5 ).
TSPO-deficient cells lost response to the tubulin stabilizing agent paclitaxel and show reduced colocalization of mitochondria with microtubules To investigate the mechanism of TSPO-mediated Dc m reduction, we examined the effect of the tubulinstabilizing agent paclitaxel (SigmaAldrich Canada Ltd.) on TSPO-deficient cells nG1 and G2G compared with the effect on their respective control cells G1 and HH. Free tubulin has been shown to regulate Dc m in cancer cells by blocking VDAC function in a PKA-dependent manner (39) (40) (41) . Free tubulin and organized microtubules were also associated with adrenocorticotropic hormoneand cAMP-stimulated steroidogenesis in murine adrenal and rat Leydig cells (42) . In the current studies, paclitaxel (100 nM; Sigma-Aldrich Canada Ltd.) significantly increased the Dc m in controls by enhancing tubulin polymerization but not in TSPO-deficient cells, indicating that the TSPO-mediated Dc m regulation involved Fig. 6A and 6B ). Data from previous mass spectrometry studies on the mitochondrial protein complex involved in steroidogenesis indicated that cytoskeletal proteins were involved in the dbcAMP treatment and that microtubule elements were lost in the lowermolecular-weight complexes, whereas the ACTG1 and vimentin proteins were upregulated in the higher molecular protein complexes (Fig. 6C) (11) . A search through the protein-protein interaction network STRING (https://stringdb.org/) showed that TSPO is associated with cytoskeletal proteins via VDAC (Fig. 6D) . Confocal images of microtubules and mitochondria show that the overlap of mitochondria and polymerized tubulin was reduced in TSPO-deficient cells (Fig. 6E-6J) . Fluorescence intensity analysis shown by scatter plots and a bar graph of Mander's overlap coefficient R also showed reduced colocalization in TSPO-deficient nG1 cells (Fig. 6K ). These confocal data suggest a TSPO-mediated microtubule-mitochondria interaction most likely occurring via the regulation of dimeric tubulin-VDAC interaction (41, 43) .
VDAC-tubulin interaction (
TSPO was involved in STAR protein mitochondrial import/function, which was correlated with reduced Dc m in TSPO-deficient cells
Immunoblot analysis showed the induction of STAR immunoreactive proteins in control G1 and HH cells after treatment with dbcAMP for 2 hours (Fig. 7A-7D ), but to a lesser extent than that seen in the TSPO-deficient nG1 and G2G cells (Fig. 7B and 7D ). The presence of increased levels of the 37-kDa cytosolic STAR and cleaved STAR protein before dbcAMP stimulation in nG1 cells suggests that although most STAR is not processed, some is imported and processed in the mitochondria (Fig. 7B) . The lack of change in the pattern of STAR before and after dbcAMP treatment in G2G cells indicates that STAR accumulated outside the mitochondria (Fig. 7D) ; no processing occurred. These observations are most likely due to the fact that STAR can be processed only by the mitochondrial Lon protease after mitochondrial import (44) . These data also suggest that STAR is imported into mitochondria in a TSPOdependent fashion. Confocal imaging of STAR-DsRed protein was used to track the STAR mitochondrial import. STAR-DsRed was found to be imported into mitochondria in control G1 cells in response to dbcAMP treatment, whereas nG1 TSPO-deficient cells showed a notable amount of protein outside the mitochondria (Fig. 7E-7L) . Similar results were obtained using HH control and G2G TSPO-deficient cells (Supplemental Fig. 6 ). Both the immunoblot analysis and confocal imaging suggest that the mitochondrial import of STAR depends on the presence of TSPO and polarized mitochondria (i.e., maintenance of its Dc m ). Microtubule-associated proteins were identified in the mitochondrial protein complexes found in bands 1 to 9, whereas actin filament-associated proteins were increased in the mitochondrial protein complexes. The mass spectrometry data were extracted from a previous study on TSPO-mediated cholesterol mitochondrial transport complexes (11) .
(D) The TSPO-associated cytoskeleton protein-protein interaction. The main interactions were retrieved from the STRING database (http://string-db. org), except that the VDAC-tubulin interaction is from a previous publication on dimeric tubulin blocking VDAC closure at negative potentials (40) . 
Discussion
Data from several independent laboratories have shown an important role of TSPO in steroidogenesis (10, 23, 25, (47) (48) (49) (50) (51) . In addition to the stimulatory effect of numerous TSPO-specific drug ligands on steroid production both in vivo and in vitro, in all steroidogenic cells and tissues tested, the role of TSPO in steroidogenesis is supported strongly by studies of the effects of the specific inhibition of TSPO-specific ligands on steroid formation (5, 52). In particular, several TSPO ligands that bind either to the drug-binding sites or to the cholesterol Reduction in DC M of the Tspo mutant cells is most likely attributable to TSPO interactions with the VDAC and tubulin (dimeric and polymerized) at the OMM (Supplemental Fig. 7 ). This conclusion is based on findings using the tubulin stabilizing reagent paclitaxel (Sigma-Aldrich Canada Ltd.) showing that TSPO interfered with a membrane lipid composition-dependent VDAC/tubulin interaction (39, 69) . Paclitaxel has been shown to bind the interior surface of microtubules (70) , and tubulin has been reported to interact with VDAC1 in regulation of mitochondrial respiration as well as Dc m (40, 41) . The Dc m depends on the flux of respiratory substrates adenosine triphosphate, adenosine diphosphate, and Pi through the VDAC, whereas the VDAC is controlled by tubulin. Adenine nucleotide translocator also plays a role in maintenance of the Dc m (39, 71) . Therefore, TSPO apparently controls cellular and mitochondrial metabolism in MA-10 cells in general via regulation of Dc m , and affects OMM permeability and/or outer and inner membrane contacts/fusion, as hypothesized previously (72) . This suggests that the contact sites are essential for dbcAMP-stimulated steroidogenesis. The changes in mitochondrial membranes may be related to TSPO-mediated membrane properties, such as their dynamics, physical properties, and facilitating or impairing of mitochondrial membrane permeabilization with dbcAMP treatment. Indeed, the Dc m is needed for mitochondrial fusion, which in turn is required for steroid biosynthesis (34) .
STAR, another protein known to be integrally involved in steroid formation, was induced in nG1 cells, suggesting the possible involvement of TSPO in STAR functioning/mitochondrial import. Thus, the Dc m is necessary for STAR protein mitochondrial import in Leydig cells in steroidogenesis (45, 73) . Our immunoblot analysis and confocal imaging results are consistent with the concept that the STAR protein works on the mitochondrial surface rather than inside the mitochondria (74) . However, whether STAR is inside mitochondria (nG1 cells) or outside mitochondria (G2G cells), it acts functionally with TSPO, an OMM protein, during hormone-stimulated steroidogenesis. How STAR functions in relationship to TSPO to deliver cholesterol into the mitochondria remains to be elucidated (72) . Nevertheless, these observations are in agreement with previous findings that TSPO is involved in STAR import into mitochondria and processing either directly or indirectly via changes in Dc m (24, 53, 75) .
Taken together, these results provide further compelling evidence for a critical role of TSPO in steroid biosynthesis and suggest that it may function at least in part via its regulation of DC m and effects on STAR synthesis and/or processing.
